2021
DOI: 10.3389/frai.2021.638410
|View full text |Cite
|
Sign up to set email alerts
|

The Promise of AI for DILI Prediction

Abstract: Drug-induced liver injury (DILI) is a common reason for the withdrawal of a drug from the market. Early assessment of DILI risk is an essential part of drug development, but it is rendered challenging prior to clinical trials by the complex factors that give rise to liver damage. Artificial intelligence (AI) approaches, particularly those building on machine learning, range from random forests to more recent techniques such as deep learning, and provide tools that can analyze chemical compounds and accurately … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
31
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 41 publications
(37 citation statements)
references
References 81 publications
(169 reference statements)
0
31
0
Order By: Relevance
“…In contrast, only the two milder levels of fibrosis were included in the selection, as severe fibrosis was observed rarely. While we focus on the described definition of adverse histopathological findings in this study, the difficulty in summarising a complex phenotype such as DILI into a binary classification, adverse or not adverse, is well established [27, 28] and is also demonstrated by the discrepancies between DILI classifications from DILIst, DILIrank and those derived by Sutherland et al based on the TG-GATEs data (S1). We are aware that also broader or more targeted phenotypes might be of interest, and we hence provide a Shiny app where results for alternative definitions of adverse and non-adverse histopathology groups can be explored.…”
Section: Resultsmentioning
confidence: 99%
“…In contrast, only the two milder levels of fibrosis were included in the selection, as severe fibrosis was observed rarely. While we focus on the described definition of adverse histopathological findings in this study, the difficulty in summarising a complex phenotype such as DILI into a binary classification, adverse or not adverse, is well established [27, 28] and is also demonstrated by the discrepancies between DILI classifications from DILIst, DILIrank and those derived by Sutherland et al based on the TG-GATEs data (S1). We are aware that also broader or more targeted phenotypes might be of interest, and we hence provide a Shiny app where results for alternative definitions of adverse and non-adverse histopathology groups can be explored.…”
Section: Resultsmentioning
confidence: 99%
“…New efforts to detect biomarkers of injured and necrotic hepatocytes seem promising, as it is important to identify APAP-induced acute liver injury patients at an early stage when lifesaving medical and surgical therapies can be provided. Going forward, AI approaches to predicting DILI could improve our understanding of the underlying mechanisms and our ability to anticipate hepatotoxicity for clinical applications [ 32 ].…”
Section: Discussionmentioning
confidence: 99%
“…Advanced organ-on-a-chip and 3D models replicating the gut-liver axis with added microbiota components could represent the right direction for future interdisciplinary research in the DILI field [ 345 , 346 , 347 , 348 ]. Moreover, the implementation of in silico prediction models, machine learning methods, and the development of comprehensive databases could further assist in selecting better and safer candidates for drug development, and predicting, with high accuracy, potential DILI [ 349 , 350 , 351 , 352 ].…”
Section: Concluding Remarks and Future Perspectivesmentioning
confidence: 99%